Illustration of Brinzolamide packaging

Notice: Product images are for illustration purposes only and may differ from the medication you receive. Packaging and appearance may vary depending on the country of origin, and generic medications may be supplied by different manufacturers. The medication, strength, and active ingredients will match your prescription. At the Canadian Pharmacy Store we prioritize your health and safety by working with licensed pharmacy partners to provide safe, high-quality medications.

GenericActive ingredient: BrinzolamideEye care medications

Brinzolamide

Brand:Azopt

Brinzolamide (Generic)

Brinzolamide

Sourced from United Kingdom Source: United Kingdom
Prescription Required
Select product strength & quantity:

Brinzolamide (Generic)

Brinzolamide

Sourced from United Kingdom Source: United Kingdom
Prescription Required
Select product strength & quantity:

Brinzolamide/Timolol (Generic)

Brinzolamide, Timolol

Sourced from Mauritius Source: Mauritius
Prescription Required
Select product strength & quantity:
Select Strength & Quantity

Choose the strength, form, and package size that match your prescription.

Send Your Prescription

Upload your prescription online, request a transfer, or have your doctor fax us.

Pharmacist Review & Delivery

Reviewed by a licensed pharmacist and shipped to your U.S. address with tracking. Shipping details.

Description

Brinzolamide (brinzolamide) is a carbonic anhydrase inhibitor listed in our Eye care medications directory and prescribed for glaucoma or raised eye pressure (1.1) (2.1). Administered via the ophthalmic route, Brinzolamide is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.

Brinzolamide is a medication containing the active pharmaceutical ingredient brinzolamide, classified pharmacologically as a carbonic anhydrase inhibitor (2.1). It is clinically indicated for the management of glaucoma or raised eye pressure as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).

Within the Eye care medications section of our catalogue, patients and prescribers frequently review Brinzolamide alongside related therapies such as Azopt (Brinzolamide), Azarga (Brinzolamide / Timolol), Simbrinza Opthalmic (Brimonidine Tartrate / Brinzolamide), and Acetazolamide.

Official Indications and Usage

Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. (1.1)

Mechanism of Action and Pharmacology

Carbonic anhydrase is an enzyme found in many tissues of the body including the eye. It catalyzes the reversible reaction involving the hydration of carbon dioxide and the dehydration of carbonic acid. In humans, carbonic anhydrase exists as a number of isoenzymes, the most active being carbonic anhydrase II, found primarily in red blood cells (RBCs), but also in other tissues. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. The result is a reduction in IOP. (1.1)

What is Glaucoma and eye pressure?

Glaucoma can damage the optic nerve and affect vision. Lowering eye pressure is one treatment approach, with regular eye-care follow-up. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Glaucoma and eye pressure condition guide for appointment questions and related therapies (2.1).

Ordering Brinzolamide from Canada for U.S. Delivery

U.S. patients can order Brinzolamide (Brinzolamide) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.

Step 1

Send Your Prescription

Step 2

Pharmacist Safety Check

  • Multi-point dosing and interaction review completed in under 1 business day.
  • Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
  • Verified under our Pharmacy Safety Standards.
Step 3

$14.99 USD Tracked Parcel

  • Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
  • Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
  • Review full shipping and delivery details.
Step 4

U.S. Street Delivery & Payment

  • Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
  • You see and approve the country of origin upfront before your card is charged.
  • Report any delayed or damaged parcel within 48 hours for prompt resolution.

Fact Table

Clinical Specification Details
Brand / Product Name Brinzolamide
Chemical / Generic Name Brinzolamide
Pharmacological Class Carbonic Anhydrase Inhibitor
Therapeutic Category Eye care medications
Same-Ingredient Catalogue Entries Azopt (Brinzolamide), Azarga (Brinzolamide / Timolol)
Molecular Weight 383.5 g/mol (2.1)
Elimination Half-Life ~111 days (1.1)
Legal Status Rx-Only (Prescription Required)
Regulatory Reference Authorities U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus
Routes of Administration Ophthalmic
Dosage Forms & Strengths Ophthalmic suspension containing brinzolamide 10 mg/mL (1%). Ophthalmic suspension containing brinzolamide 10 mg/mL (1%)
Primary Indications Glaucoma Or Raised Eye Pressure
Pregnancy & Breastfeeding Consult Doctor / Prescriber before use
FDA UNII Identifier 9451Z89515
NLM RxNorm Concept ID (RxCUI) 308805
FDA Application License ANDA204884
Official DailyMed SetID fb7229d4-522e-4cb2-b513-9d34f3ded591
Catalogue Index Links Letter B Index · All Medications · All Categories

Directions

Dosage and Administration Overview

The recommended dose is one drop of brinzolamide ophthalmic suspension in the affected eye(s) 3 times daily. Brinzolamide ophthalmic suspension may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least 10 minutes apart. (1.1)

Presentations and Strengths

Ophthalmic suspension containing brinzolamide 10 mg/mL (1%). (1.1)

Administration Guidance

Instill Brinzolamide into the affected eye(s) exactly as directed by your eye-care specialist (1.1). Wash your hands before administration, avoid touching the dropper tip to the eye or any surface to maintain sterility, and wait at least 5 to 10 minutes between different ophthalmic medications.

Missed Dose Guidance

If you miss a scheduled dose of Brinzolamide, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).

Ingredients

Active Pharmaceutical Ingredient

The active ingredient in Brinzolamide is brinzolamide (2.1). Other catalogue entries containing brinzolamide include Azopt (Brinzolamide) and Azarga (Brinzolamide / Timolol).

Excipients and Formulation Carriers

Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).

Cautions and important safety information

Contraindications

Brinzolamide ophthalmic suspension is contraindicated in patients who are hypersensitive to any component of this product. Hypersensitivity to any component of this product. (1.1)

Key Clinical Precautions

Before starting or continuing Brinzolamide, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):

  • Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
  • Severe cutaneous adverse reactions (SCARs): Rare but serious skin reactions such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) require immediate discontinuation at the first sign of a blistering rash, mucosal lesions, or fever.
  • Hematologic monitoring (cytopenias): Periodic complete blood counts (CBC) may be required to monitor for neutropenia, anemia, or thrombocytopenia.

Pregnancy, Lactation, and Special Populations

There are no adequate and well-controlled studies in pregnant women to inform drug-associated risk. In reproductive toxicity studies, brinzolamide administered orally to rats induced fetal toxicity at 375-times the recommended human ophthalmic dose (rhod) based on mg/kg. In rabbits, no fetal toxicity was observed following oral administration. The background risk of major birth defects and miscarriage for the indicated population is unknown; however, in the U.S. General population, the estimated background risk of major birth defects is 2% to 4%, and of miscarriage is 15% to 20%, of clinically recognized pregnancies. (1.1)

Interactions

Official Drug Interaction Overview

There is a potential additive effect of the known systemic effects of carbonic anhydrase inhibition in patients receiving both oral and topical carbonic anhydrase inhibitors Rare instances of acid-base alterations have occurred with high-dose salicylate therapy. (1.1)

Side effects

Like all medications, Brinzolamide can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):

  • Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; eating smaller, lower-fat meals and avoiding lying down immediately after eating may help reduce nausea.
  • Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
  • Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
  • Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
  • Xerostomia (dry mouth): Sipping water or using sugar-free lozenges can help relieve oral dryness.
  • Fatigue or tiredness: May occur during initial adjustment or dose changes.

Clinical Trial and Postmarketing Adverse Reactions

Most common adverse reactions (incidence 5 to 10%) are blurred vision and bitter, sour, or unusual taste Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to the rates in the clinical trials of another drug and may not reflect the rates observed in practice. In clinical studies of brinzolamide ophthalmic suspension, the most frequently reported adverse reactions reported in 5% to 10% of patients were blurred vision and bitter, sour or unusual taste. Adverse reactions occurring in 1% to 5% of patients were blepharitis, dermatitis, dry eye, foreign body sensation, headache, hyperemia, ocular discharge, ocular discomfort, ocular keratitis, ocular pain, ocular pruritus and rhinitis. (1.1)

When to Seek Immediate Medical Attention

Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).

Storage and handling

Brinzolamide ophthalmic suspension USP, 1% is supplied in natural, round boston, LDPE bottles with an extended controlled drop tip lldpe tip as follows: 10 mL NDC 68682-464-10 15 mL NDC 68682-464-15 Storage and Handling Store brinzolamide ophthalmic suspension USP, 1% at 4° to 30°C (39° to 86°F). Shake well before use. After opening, brinzolamide ophthalmic suspension USP, 1% can be used until the expiration date on the bottle. (1.1)

Store Brinzolamide in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).

What is a generic drug?

A generic medication contains the exact same active pharmaceutical ingredient (brinzolamide) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.

While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.

Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Eye care medications directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.

Frequently Asked Questions About Brinzolamide

What is Brinzolamide and what active ingredient does it contain?

Brinzolamide is a carbonic anhydrase inhibitor containing the active pharmaceutical ingredient brinzolamide. It is supplied for ophthalmic administration and requires a valid prescription where applicable.

How does Brinzolamide work in the body?

Carbonic anhydrase is an enzyme found in many tissues of the body including the eye. It catalyzes the reversible reaction involving the hydration of carbon dioxide and the dehydration of carbonic acid. In humans, carbonic anhydrase exists as a number of isoenzymes, the most active being carbonic anhydrase II, found primarily in red blood cells (RBCs), but also in other tissues.

What conditions is Brinzolamide prescribed to treat?

Brinzolamide is primarily indicated for glaucoma or raised eye pressure. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.

How should I take or use Brinzolamide?

Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Brinzolamide is administered via the ophthalmic route. Instill or apply it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.

What are the most common side effects of Brinzolamide?

Commonly reported side effects of Brinzolamide include feeling sick, loose stools, headache, dizziness, dry mouth, and tiredness. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.

What medications or substances can interact with Brinzolamide?

Share your full list of current prescription medications, over-the-counter products, and supplements with your prescriber and pharmacist so they can screen for any potential drug interactions.

Can Brinzolamide be used during pregnancy or breastfeeding?

If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Brinzolamide to weigh the clinical benefits and potential risks.

Do I need a prescription to buy Brinzolamide online from Canada?

Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Brinzolamide (Brinzolamide) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).

What is the brand-name version of Brinzolamide (Brinzolamide) at a Canada pharmacy?

Yes. Brinzolamide is the bioequivalent generic formulation of brand-name Azopt, containing the same active ingredient (Brinzolamide) and strength options.

How is Brinzolamide shipped to U.S. residents, and how much does shipping cost?

Brinzolamide ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.

How can I send or transfer my Brinzolamide prescription, or ask about an unlisted strength?

You can upload a clear photo or PDF of your Brinzolamide prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.

References & Official Sources

Clinical, pharmacological, and safety facts for Brinzolamide are compiled directly from official regulatory prescribing labels and primary biomedical databases:

  1. (1.1) Brinzolamide (Brinzolamide), Official Prescribing Information. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
  2. (2.1) MedlinePlus Medical Encyclopedia: Glaucoma. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
  3. (3.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).

Related Condition Guides

Related Guides

Call 1-888-868-1920Help